Parexel Honored with 2015 Clinical Innovator of the Year Award from Partnerships in Clinical Trials
Award highlights Company’s innovative Perceptive MyTrials® Data-Driven Monitoring solution and development team
BOSTON, April 24, 2015 – Parexel International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced that Partnerships in Clinical Trials named Parexel’s Drew Garty, Senior Director, Product Management, the 2015 Clinical Innovator of the Year. The honor recognizes Mr. Garty’s leadership of the product development team for the Company’s Perceptive MyTrials® Data-Driven Monitoring solution.
After accepting the award Thursday night during the 2015 Partnership Awards in Boston, Mr. Garty stated, “The development of our Perceptive MyTrials Data-Driven Monitoring (DDM) solution was a significant team effort with a clear goal of meeting a customer need. I am honored to accept this award from Partnerships in Clinical Trials on behalf of the team in recognition of Parexel’s innovative approach to risk-based monitoring.”
On-site monitoring is a critical aspect of trial management, with the primary function of identifying and mitigating patient safety or data quality risks at investigative sites. The U.S. Food and Drug Administration (FDA) and other regulatory bodies have issued guidance to assist sponsors in developing risk-based monitoring strategies. The goal of these strategies is to enhance patient protection and improve trial data quality through more effective study oversight.
The Perceptive MyTrials Data-Driven Monitoring solution uses a unique algorithmic-based approach to clinical monitoring to determine risk and monitor workload, enabling flexible and scalable decision making. DDM allows drug developers to accurately identify study risks and efficiently determine the most effective monitoring interventions required. As a result, drug developers can enhance quality and patient safety, reduce costs and ensure regulatory compliance.
“Through the Perceptive MyTrials Data-Driven Monitoring solution, we have greater insights into study data. These insights can make clinical trial participation safer for patients, improve decision making during the drug development journey and offer cost efficiencies for sponsors,” said Xavier Flinois, President of Parexel Informatics. “Our data-driven monitoring solution builds on Parexel’s established history of developing innovative technologies to continuously improve clinical processes, and we are thrilled to be recognized by Partnerships in Clinical Trials.”
About Partnership in Clinical Trials and the Partnership Awards
The Partnerships in Clinical Trials event is North America's largest conference serving the global clinical trials, operations and outsourcing community. The Partnership Awards honor the accomplishments of clinical trial leaders who have influenced change within the industry through innovation. The Clinical Innovator of the Year Award honors a person or company with a disruptive technology platform or a new way to optimize clinical development that has increased the efficiency of clinical trials.
